Additionally, dihydroartemisinin showed anticancer effects against esophageal cancer by inhibiting cell migration, inducing autophagy [62] and cell cycle arrest [63,64], and targeting AKT1, p70S6K [65], and human telomerase reverse transcriptase [66]. The gene discussed is AKT1; the disease is esophageal cancer.